Home » Topics » Conferences

Conferences
RSS

HCV NS5B polymerase inhibitor ABT-072 shows promising safety and pharmacokinetics

April 28, 2010

Final data disclosed from PROTECT trial of PEG-IFN-alfa2b/ribavirin

April 28, 2010

Temozolomide shows activity in pituitary tumors and carcinomas

April 27, 2010

Dual TLR7 and TLR9 antagonist has therapeutic effects in mouse model of atherosclerosis

April 27, 2010

EMD-1214063 displays potent and selective c-Met inhibition

April 27, 2010

Updated phase I data disclosed on IMO-2125 in HCV infection

April 27, 2010

INT-747 promising as add-on therapy to ursodeoxycholic acid for primary biliary cirrhosis

April 27, 2010

Hepatitis C treatment SCY-635 associated with a high barrier to resistance

April 27, 2010

Humoral responses to DC-Melvac cancer vaccine seen in melanoma patients

April 27, 2010

Preclinical data support virodhamine as potential antifibrogenic mediator

April 26, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...